Skip to content
All Sections
Subscribe Now
76°F
Thursday, May 23rd 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
76°F
Thursday, May 23rd 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
eTrendy Stock
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressConnect.ai
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
Today 17:12 EDT
From
Nimbus Therapeutics, LLC
Via
Business Wire
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
Today 17:10 EDT
From
Barnes & Noble Education
Via
Business Wire
Tickers
BNED
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
Today 17:10 EDT
From
Agenus Inc.
Via
Business Wire
Tickers
AGEN
Federman & Sherwood Investigates Association of California School Administrators for Data Breach
Today 17:06 EDT
From
Federman & Sherwood
Via
Business Wire
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
Today 17:05 EDT
From
Bristol Myers Squibb
Via
Business Wire
Tickers
BMY
TelevisaUnivision Announces Pricing of $1.0 Billion Debt
Today 17:05 EDT
From
TelevisaUnivision
Via
Business Wire
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Today 17:05 EDT
From
Bicycle Therapeutics plc
Via
Business Wire
Tickers
BCYC
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
Today 17:05 EDT
From
Aulos Bioscience
Via
Business Wire
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
Today 17:04 EDT
From
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
Via
Business Wire
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
Today 17:02 EDT
From
Kroll Bond Rating Agency, LLC
Via
Business Wire
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
Today 17:02 EDT
From
Stellar Bancorp, Inc.
Via
Business Wire
Tickers
STEL
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer
Today 17:01 EDT
From
Verastem Oncology
Via
Business Wire
Tickers
VSTM
NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
Today 17:01 EDT
From
NMDP
Via
Business Wire
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
Today 17:00 EDT
From
Iambic Therapeutics
Via
Business Wire
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
Today 17:00 EDT
From
Comvest Partners
Via
Business Wire
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
Today 17:00 EDT
From
Orca Bio
Via
Business Wire
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
Today 17:00 EDT
From
EMD Serono
Via
Business Wire
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
Today 17:00 EDT
From
Xspray Pharma AB
Via
Business Wire
Klaviyo to Present at the William Blair Growth Stock Conference
Today 17:00 EDT
From
Klaviyo, Inc.
Via
Business Wire
Tickers
KVYO
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Today 17:00 EDT
From
NeraCare
Via
Business Wire
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Today 17:00 EDT
From
Genmab A/S
Via
Business Wire
Tickers
GMAB
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
Today 17:00 EDT
From
Incendia Therapeutics
Via
Business Wire
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Today 17:00 EDT
From
City of Hope
Via
Business Wire
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
Today 17:00 EDT
From
SOTIO Biotech
Via
Business Wire
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
Today 17:00 EDT
From
Legend Biotech Corporation
Via
Business Wire
Tickers
LEGN
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Today 17:00 EDT
From
Obsidian Therapeutics, Inc.
Via
Business Wire
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
Today 17:00 EDT
From
AffyImmune Therapeutics
Via
Business Wire
Dentalcorp Announces Annual General Meeting Voting Results
Today 17:00 EDT
From
dentalcorp Holdings Ltd.
Via
Business Wire
Tickers
TSX:DNTL
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
Today 17:00 EDT
From
The Menarini Group
Via
Business Wire
Ligand to Participate in Upcoming Investor Conferences
Today 16:59 EDT
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Tickers
LGND
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close